Madrigal Pharma's REZDIFFRA sees 33% Q1 2025 sales growth, strong EU progress, and promising MASH data. Read why I maintain ...

Altimmune, Inc. (ALT) on Thursday said that its mid-stage study of Pemvidutide in metabolic dysfunction-associated ...

Thiogenesis Therapeutics, Inc. (TSXV: TTI) (OTCQX: TTIPF), a clinical-stage biopharmaceutical company developing next-generation thiol-based therapies for mitochondrial disease and pediatric metabolic ...

Rebecca Keen believes a full-body MRI may have saved her life, but doctors say getting one could cause more harm than good.

In addition to being faster and less invasive than a traditional tissue biopsy, the blood test is also potentially more accurate.

Liver transplant is a lifesaving surgery, but a significant number of patients experience organ rejection or other ...

MASH improvement was defined as a decrease of at least 2 points in non-alcoholic fatty liver disease activity score (NAS) or a NAS of 3 points or less. After an end of study biopsy at week 48, 53% ...

Considering that a biopsy sample taken from an adult corresponds to a fraction of just 1/50,000th to 1/100,000th of the whole liver, a biopsy specimen would seem to be inadequate in the case of ...